← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 1, 2004Last known activity
Nov 14, 2023
Timeline
1990s
- Jun 1, 1994
Diamyd— Founded
Drugs by trial phase (11 distinct, 16 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Recent trials (17)
- NCT05683990Lead sponsorPhase 2Nov 14, 2023
- NCT05351879CollaboratorPhase 1/Phase 2May 9, 2022
- NCT05018585Lead sponsorPhase 3Dec 31, 2021
- NCT04262479CollaboratorPhase 2Feb 29, 2020
- NCT03635437CollaboratorPhase 1/Phase 2Sep 5, 2018
- NCT03345004Lead sponsorPhase 2Dec 20, 2017
- NCT02464033CollaboratorPhase 2May 1, 2015
- NCT02352974CollaboratorPhase 1Jan 1, 2015
- NCT02002130CollaboratorPhase 1Jan 1, 2015
- NCT01785108CollaboratorPhase 2Feb 1, 2013
- NCT01291901Study directorPhase 2Jan 1, 2011
- NCT01291901Lead sponsorPhase 2Jan 1, 2011
- NCT00751842Lead sponsorPhase 3Sep 1, 2008
- NCT00723411Lead sponsorPhase 3Jul 1, 2008
- NCT00804076Lead sponsorPhase 1Feb 1, 2008
Details
- Founded
- Stockholm, SE Jun 1, 1994
- Last known activity
- Nov 14, 2023